These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7904728)

  • 1. Plasma membrane enzymes in human breast carcinoma: relationship with serum hormones.
    Ramalingam V; Krishnamoorthy G; Govindarajulu P
    Neoplasma; 1993; 40(6):363-7. PubMed ID: 7904728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzymes of carbohydrate metabolism in human breast carcinoma: relationship with serum hormones.
    Ramalingam V; Krishnamoorthy G; Govindarajulu P
    Neoplasma; 1994; 41(1):49-54. PubMed ID: 8202196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risk factors and correlations with some tumor markers in the incidence of breast cancer in pre- and post-menopausal patients].
    Salazar EL; García MO; Avila A
    Ginecol Obstet Mex; 1998 Jul; 66():263-6. PubMed ID: 9737065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Changes in prolactin plasma levels in relation to menopausal status in primary breast carcinoma].
    Pavić S; Pavić Z
    Med Pregl; 1995; 48(5-6):159-61. PubMed ID: 7565335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating hormone levels in breast cancer patients. correlation with serum tumor markers and the clinical and biological features of the tumors.
    Hernández L; Nuñez-Villarl MJ; Martínez-Arribas F; Pollán M; Schneider J
    Anticancer Res; 2005; 25(1B):451-4. PubMed ID: 15816610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex steroid hormones in serum and tissue of benign and malignant breast tumor patients.
    Mady EA; Ramadan EE; Ossman AA
    Dis Markers; 2000; 16(3-4):151-7. PubMed ID: 11381198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of HER-2/neu, ER and PCNA expression in premenopausal and postmenopausal patients with breast carcinoma.
    Zheng W; Zheng J; Ma L; Meng F; Huang L; Ma D
    APMIS; 2005 Mar; 113(3):175-81. PubMed ID: 15799760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective study of plasma prolactin concentrations and risk of premenopausal and postmenopausal breast cancer.
    Tworoger SS; Eliassen AH; Sluss P; Hankinson SE
    J Clin Oncol; 2007 Apr; 25(12):1482-8. PubMed ID: 17372279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenobiotic-metabolising enzymes in patients with adenocarcinoma of the breast: correlation with clinical stage and menopausal status.
    Kumaraguruparan R; Chandra Mohan KV; Nagini S
    Breast; 2006 Feb; 15(1):58-63. PubMed ID: 16002293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationships between circulating hormone levels, mammographic percent density and breast cancer risk factors in postmenopausal women.
    Johansson H; Gandini S; Bonanni B; Mariette F; Guerrieri-Gonzaga A; Serrano D; Cassano E; Ramazzotto F; Baglietto L; Sandri MT; Decensi A
    Breast Cancer Res Treat; 2008 Mar; 108(1):57-67. PubMed ID: 17468953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA oxidation and antioxidant status in breast cancer.
    Himmetoglu S; Dincer Y; Ersoy YE; Bayraktar B; Celik V; Akcay T
    J Investig Med; 2009 Aug; 57(6):720-3. PubMed ID: 19494787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of serum hormones in premenopausal and postmenopausal women over a one-year period.
    Muti P; Trevisan M; Micheli A; Krogh V; Bolelli G; Sciajno R; Berrino F
    Cancer Epidemiol Biomarkers Prev; 1996 Nov; 5(11):917-22. PubMed ID: 8922301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulatory influence of soy protein isolate on breast secretion in pre- and postmenopausal women.
    Petrakis NL; Barnes S; King EB; Lowenstein J; Wiencke J; Lee MM; Miike R; Kirk M; Coward L
    Cancer Epidemiol Biomarkers Prev; 1996 Oct; 5(10):785-94. PubMed ID: 8896889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma levels of prolactin in women with dysplasia and tumors of the breast (fibroadenoma and carcinoma of the breast)].
    Iturburu Belmonte IM; Basáñez Amuchastegui A; Jiménez Jiménez E; López de Tejada Cabeza I; Goicoechea García J; Méndez Martín J
    Rev Quir Esp; 1988; 15(1):17-21. PubMed ID: 3153353
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinico pathological study of malignant breast tumours with special reference to cellular enzymatic activity.
    Srivastava VK; Wahi K; Gupta AK; Mittal VP; Rajvanshi VS
    Indian J Cancer; 1976 Sep; 13(3):220-6. PubMed ID: 1010584
    [No Abstract]   [Full Text] [Related]  

  • 16. Differences in the estrogen content of breast adipose tissue in women by menopausal status and hormone use.
    O'Brien SN; Anandjiwala J; Price TM
    Obstet Gynecol; 1997 Aug; 90(2):244-8. PubMed ID: 9241302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective study of estradiol and breast cancer in Japanese women.
    Kabuto M; Akiba S; Stevens RG; Neriishi K; Land CE
    Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):575-9. PubMed ID: 10868691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women.
    Reinier KS; Vacek PM; Geller BM
    Breast Cancer Res Treat; 2007 Jul; 103(3):343-8. PubMed ID: 17063272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human placental ecto-enzymes: studies on the plasma membrane anchorage and effect of inhibitors of ATP-metabolizing enzymes.
    Chayet L; Collados L; Kettlun AM; Campos E; Traverso-Cori A; García L; Valenzuela MA
    Res Commun Mol Pathol Pharmacol; 1997 Apr; 96(1):14-24. PubMed ID: 9178364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
    Tworoger SS; Sluss P; Hankinson SE
    Cancer Res; 2006 Feb; 66(4):2476-82. PubMed ID: 16489055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.